Expression level of costimulatory receptor ICOS is critical for determining the polarization of helper T cell function

Transplant Immunology

Volumn 15, Issue 4, 2006, Pages 255-263

  Watanabe, Shiho ^a   Ogawa, Shuhei ^a   Hara, Yasushi ^a   Tanabe, Kazunari ^b   Toma, Hiroshi ^b   Abe, Ryo ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Costimulation; Graft versus host disease; ICOS; Th1 Th2 cells

Indexed keywords

CD28 ANTIGEN; INDUCIBLE COSTIMULATOR; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL POLARITY; CELLULAR IMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION;

ACUTE DISEASE; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GRAFT VS HOST DISEASE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 33646105623     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.01.002     Document Type: Article

References (32)

1. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat Rev Immunol 2 2 (2002) 116-126
2. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397 6716 (1999) 263-266
3. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402 6763 (1999) 827-832
4. + T cells. J Immunol 165 9 (2000) 5035-5040
5. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., et al. ICOS is critical for CD40-mediated antibody class switching. Nature 409 6816 (2001) 102-105
6. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeham A., et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261 5121 (1993) 609-612
7. Dong C., Temann U.A., and Flavell R.A. Cutting edge: critical role of inducible costimulator in germinal center reactions. J Immunol 166 6 (2001) 3659-3662
8. Lu P., Zhou X., Chen S.J., Moorman M., Morris S.C., Finkelman F.D., et al. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J Exp Med 180 2 (1994) 693-698
9. Perrin P.J., Scott D., June C.H., and Racke M.K. B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis. Immunol Res 14 3 (1995) 189-199
10. Pearson T.C., Alexander D.Z., Winn K.J., Linsley P.S., Lowry R.P., and Larsen C.P. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57 12 (1994) 1701-1706
11. Hakim F.T., Cepeda R., Gray G.S., June C.H., and Abe R. Acute graft-versus-host reaction can be aborted by blockade of costimulatory molecules. J Immunol 155 4 (1995) 1757-1766
12. Saha B., Jaklic B., Harlan D.M., Gray G.S., June C.H., and Abe R. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig. J Immunol 157 9 (1996) 3869-3875
13. Coyle A.J., Lehar S., Lloyd C., Tian J., Delaney T., Manning S., et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13 1 (2000) 95-105
14. Ozkaynak E., Gao W., Shemmeri N., Wang C., Gutierrez-Ramos J.C., Amaral J., et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2 7 (2001) 591-596
15. Miyahira Y., Akiba H., Ogawa S.H., Ishi T., Watanabe S., Kobayashi S., et al. Involvement of ICOS-B7RP-1 costimulatory pathway in the regulation of immune responses to Leishmania major and Nippostrongylus brasiliensis infections. Immunol Lett 89 2-3 (2003) 193-199
16. Sakamoto S., Tezuka K., Tsuji T., Hori N., and Tamatani T. AILIM/ICOS: its expression and functional analysis with monoclonal antibodies. Hybrid Hybridomics 20 5-6 (2001) 293-303
17. + splenic T cells after CD28 receptor ligation. J Immunol 154 3 (1995) 985-997
18. Ogawa S., Nagamatsu G., Watanabe M., Watanabe S., Hayashi T., Horita S., et al. Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease. J Immunol 167 10 (2001) 5741-5748
19. Gleichmann E., Van Elven E.H., and Van der Veen J.P. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12 2 (1982) 152-159
20. + T cells. J Immunol 155 5 (1995) 2396-2406
21. Hamilton B.L., Bevan M.J., and Parkman R. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens. J Immunol 126 2 (1981) 621-625
22. Allen R.D., Staley T.A., and Sidman C.L. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur J Immunol 23 2 (1993) 333-337
23. Grewal I.S., and Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16 (1998) 111-135
24. Krishnan S., Warke V.G., Nambiar M.P., Wong H.K., Tsokos G.C., and Farber D.L. Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression. Blood 97 12 (2001) 3851-3859
25. + T cells during Th cell development. J Immunol 171 2 (2003) 783-794
26. Nurieva R.I., Duong J., Kishikawa H., Dianzani U., Rojo J.M., Ho I., et al. Transcriptional regulation of th2 differentiation by inducible costimulator. Immunity 18 6 (2003) 801-811
27. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 14 (1996) 233-258
28. Via C.S., Rus V., Nguyen P., Linsley P., and Gause W.C. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD. J Immunol 157 9 (1996) 4258-4267
29. Watanabe M., Watanabe S., Hara Y., Harada Y., Kubo M., Tanabe K., et al. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling. J Immunol 174 4 (2005) 1989-1996
30. Lighvani A.A., Frucht D.M., Jankovic D., Yamane H., Aliberti J., Hissong B.D., et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A 98 26 (2001) 15137-15142
31. Iwai H., Kozono Y., Hirose S., Akiba H., Yagita H., Okumura K., et al. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J Immunol 169 8 (2002) 4332-4339
32. Totsuka T., Kanai T., Iiyama R., Uraushihara K., Yamazaki M., Okamoto R., et al. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis. Gastroenterology 124 2 (2003) 410-421